Archived Research

Past Collaborative Studies Completed

• Oral Interferon Tau
• Treatment decreases B cells and antibodies against the nervous system
• Add-on therapy for patients doing poorly on interferon therapy
• Lipitor (atorvastin) for patients with early multiple sclerosis
• Memantine for MS cognitive impairment
• Recombinant T Cell Ligand Therapy

Click Here to View Past Collaborative Studies Information

Past Single Site Studies Completed

Some very novel agents are currently being developed by individual Center Without Walls funded centers. Single-site studies serve the valuable function of deriving preliminary data that, if encouraging, will come to fruition as larger collaborative trials:

• Vaccination with a portion of the T cell receptor, Neurovax
• Oral alpha lipoic acid
• Neuroprotection with riluzole in early MS
• Salbutamol and Copaxone
• Omega-3 fatty acid in the treatment of depression and as an immunomodulator
• American ginseng for MS fatigue
• High dose cyclophosphamide study
• Ginkgo Biloba for Cognitive Impairment in MS
• CTLA4-Ig
• Anti-CD3 Therapy

Click Here to View Past Single Site Studies Information